Intraperitoneal chemotherapy in ovarian carcinoma. 1987

E A Runhaar, and A T van Oosterom, and E A de Bruijn, and W W ten Bokkel Huinink

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

E A Runhaar, and A T van Oosterom, and E A de Bruijn, and W W ten Bokkel Huinink
September 2001, Harefuah,
E A Runhaar, and A T van Oosterom, and E A de Bruijn, and W W ten Bokkel Huinink
November 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
E A Runhaar, and A T van Oosterom, and E A de Bruijn, and W W ten Bokkel Huinink
January 1987, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
E A Runhaar, and A T van Oosterom, and E A de Bruijn, and W W ten Bokkel Huinink
May 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
E A Runhaar, and A T van Oosterom, and E A de Bruijn, and W W ten Bokkel Huinink
June 2005, Future oncology (London, England),
E A Runhaar, and A T van Oosterom, and E A de Bruijn, and W W ten Bokkel Huinink
September 1988, Hematology/oncology clinics of North America,
E A Runhaar, and A T van Oosterom, and E A de Bruijn, and W W ten Bokkel Huinink
February 1991, Seminars in oncology,
E A Runhaar, and A T van Oosterom, and E A de Bruijn, and W W ten Bokkel Huinink
July 1988, Nederlands tijdschrift voor geneeskunde,
E A Runhaar, and A T van Oosterom, and E A de Bruijn, and W W ten Bokkel Huinink
August 1989, Seminars in oncology,
E A Runhaar, and A T van Oosterom, and E A de Bruijn, and W W ten Bokkel Huinink
March 2009, Nederlands tijdschrift voor geneeskunde,
Copied contents to your clipboard!